Evidence map›Paper›PMID 36543877›Full record

ArticleCommunications biology2022

Author Correction: Beyond noise to function: reframing the global brain activity and its dynamic topography.

Jianfeng Zhang, Georg Northoff

Registry-linked trialAbstract readPublished Erratum
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06782958 (A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of FHND1002 Granules After Single and Multiple Doses in Healthy Adult Volunteers), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06782958 phase1enrolling by invitationnot on this mapstarted 2024, after this paper: background citation

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of FHND1002 Granules After Single and Multiple Doses in Healthy Adult Volunteers

TypeinterventionalSponsorJiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.Ran2024 to 2025Enrolled72ConditionsAmyotrophic Lateral Sclerosis (ALS)Arms50mg FHND1002, 100mg FHND1002, 150 mg FHND1002, 200 mg FHND1002(fasting), 250mg FHND1002
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Jianfeng Zhang *Center for Brain Disorders and Cognitive Sciences, Shenzhen University, Shenzhen, China. zhangjf111@gmail.com.ORCID http://orcid.org/0000-0002-3591-3219
Georg Northoff *Mental Health Center, Zhejiang University School of Medicine, Hangzhou, China. georg.northoff@theroyal.ca.ORCID http://orcid.org/0000-0002-5236-0951

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36543877
PMCPMC9772390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.